Showing results (1-10 of 832) with videos related to
Sort By:
Pageof 84
Current Oncology Reports|April 1, 2017
Immunotherapy for Esophageal Squamous Cell CarcinomaTakashi Kojima, Toshihiko DoiCancer Chemotherapy and Pharmacology|May 4, 2016
A phase I study evaluating cixutumumab, a type 1 insulin-like growth factor receptor inhibitor, given every 2 or 3 weeks in Japanese patients with advanced solid tumorsToshihiko Doi, Kohei Shitara, Takashi Kojima, et al.Cancer Chemotherapy and Pharmacology|December 5, 2016
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumorsToshihiko Doi, Nozomu Fuse, Takayuki Yoshino, et al.BMC Cancer|January 11, 2017
Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.International Journal of Cancer|October 26, 2011
Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II studyTomonori Yano, Manabu Muto, Keiko Minashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Chemotherapy for GI and pancreatic NETs]Toshihiko DoiGastrointestinal Endoscopy|November 27, 2015
Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinomaKen Hatogai, Tomonori Yano, Takashi Kojima, et al.Journal of Gastroenterology|July 27, 2007
Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapyAyumu Hosokawa, Toshiro Sugiyama, Atsushi Ohtsu, et al.American Journal of Clinical Oncology|December 20, 2007
A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancerSatoshi Takeuchi, Atsushi Ohtsu, Toshihiko Doi, et al.Pageof 84